Literature DB >> 24742875

Pro-inflammatory cytokine levels are raised in female schizophrenia patients treated with clozapine.

Kara E O'Connell1, Jogin Thakore2, Kumlesh K Dev3.   

Abstract

BACKGROUND: We have previously shown that the neurotrophic factor, S100B, is raised in serum samples of female patients with schizophrenia, but not male patients, compared to controls, and this may be associated with raised BMI. Here we analysed the levels of additional proinflammatory cytokines in patients with schizophrenia to further investigate these gender differences.
METHODS: The levels of six cytokines (IL1β, IL6, IL8, IL17, IL23, TNFα) were measured in serum samples obtained from patients with schizophrenia, treated with clozapine (n=91) and compared with healthy controls (n=50). Individual cytokine levels were measured using dot-immunoblotting methods and a 'cytokine signature' was also generated by summing all 6 cytokines. Treatment time, patient age, gender, illness severity and metabolic parameters were also measured.
RESULTS: The levels of proinflammatory cytokines and BMI were significantly raised in female, but not male, patients treated with clozapine compared to healthy controls. Compared to individual cytokines, the 'cytokine signature' analysis showed less scatter of data although this 'cytokine signature' method did not improve separation of individual patients and controls.
CONCLUSIONS: This study supports previous findings that raised BMI, which is likely associated with increased number of adipocytes, may contribute to increased cytokine serum concentrations in females.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antipsychotics; Biomarker; Clozapine; Cytokines; Immune system; Schizophrenia

Mesh:

Substances:

Year:  2014        PMID: 24742875     DOI: 10.1016/j.schres.2014.03.020

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  15 in total

Review 1.  Effects of psychotropic drugs on inflammation: consequence or mediator of therapeutic effects in psychiatric treatment?

Authors:  David Baumeister; Simone Ciufolini; Valeria Mondelli
Journal:  Psychopharmacology (Berl)       Date:  2015-08-14       Impact factor: 4.530

Review 2.  Safety of antipsychotics for the treatment of schizophrenia: a focus on the adverse effects of clozapine.

Authors:  Domenico De Berardis; Gabriella Rapini; Luigi Olivieri; Domenico Di Nicola; Carmine Tomasetti; Alessandro Valchera; Michele Fornaro; Fabio Di Fabio; Giampaolo Perna; Marco Di Nicola; Gianluca Serafini; Alessandro Carano; Maurizio Pompili; Federica Vellante; Laura Orsolini; Giovanni Martinotti; Massimo Di Giannantonio
Journal:  Ther Adv Drug Saf       Date:  2018-02-06

3.  Evaluating the Hypothesis That Schizophrenia Is an Inflammatory Disorder.

Authors:  Brian J Miller; David R Goldsmith
Journal:  Focus (Am Psychiatr Publ)       Date:  2020-11-05

4.  Inflammation in Schizophrenia: Cytokine Levels and Their Relationships to Demographic and Clinical Variables.

Authors:  Ellen E Lee; Suzi Hong; Averria Sirkin Martin; Lisa T Eyler; Dilip V Jeste
Journal:  Am J Geriatr Psychiatry       Date:  2016-10-17       Impact factor: 4.105

Review 5.  Functional Implications of the IL-23/IL-17 Immune Axis in Schizophrenia.

Authors:  Monojit Debnath; Michael Berk
Journal:  Mol Neurobiol       Date:  2016-11-29       Impact factor: 5.590

6.  Pro-inflammatory cytokine levels are elevated in female patients with schizophrenia treated with clozapine.

Authors:  Xiaoping Yuan; Song Wang; Yudong Shi; Yating Yang; Yulong Zhang; Lei Xia; Kai Zhang; Huanzhong Liu
Journal:  Psychopharmacology (Berl)       Date:  2022-01-26       Impact factor: 4.530

Review 7.  Towards an Immunophenotype of Schizophrenia: Progress, Potential Mechanisms, and Future Directions.

Authors:  Brian J Miller; David R Goldsmith
Journal:  Neuropsychopharmacology       Date:  2016-09-22       Impact factor: 7.853

8.  Do proinflammatory cytokines play a role in clozapine-associated glycometabolism disorders?

Authors:  Tongtong Zhao; Kai Zhang; Yelei Zhang; Yating Yang; Xiaoshuai Ning; Yu Hu; Xiaoyue Li; Yulong Zhang; Lei Xia; Zhenhua Ren; Huanzhong Liu
Journal:  Psychopharmacology (Berl)       Date:  2021-03-27       Impact factor: 4.530

9.  Inflammation and Elevation of Interleukin-12p40 in Patients with Schizophrenia.

Authors:  Nora Bedrossian; Mariam Haidar; Jawad Fares; Firas H Kobeissy; Youssef Fares
Journal:  Front Mol Neurosci       Date:  2016-03-22       Impact factor: 5.639

10.  The value of interleukin 6 as a peripheral diagnostic marker in schizophrenia.

Authors:  Kayla A Chase; Jackson J Cone; Cherise Rosen; Rajiv P Sharma
Journal:  BMC Psychiatry       Date:  2016-05-20       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.